Progenitor (PGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Progenitor (PGEN)

PGEN 4.140

+2.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Czechsinthemail who wrote (57)	3/20/1998 3:54:00 PM
From: Steve Lokness	Read Replies (1) of 106

Richard & Baird; Doesn't todays announcement really confirm PGEN's science as it relates to delivery and as such mean that CHIR will likely take advantage of the agreement with PGEN? It seems to me the announcement not only speaks to the tumor issue but more importantly to the delivery where PGEN has the several patents? Richard you mentioned that it would be possible to find the status of the Chiron/Viagene and PGEN agreement. I do not follow CHIR, are you suggesting to call them about it or to call PGEN. I'm not sure what you meant. Along these lines, what do you think of TGEN? Steve

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next